241 related articles for article (PubMed ID: 34737343)
21. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
Kourie JI
Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
[TBL] [Abstract][Full Text] [Related]
22. Cellular prion protein gene polymorphisms linked to differential scrapie susceptibility correlate with distinct residue connectivity between secondary structure elements.
Soto P; Claflin IA; Bursott AL; Schwab-McCoy AD; Bartz JC
J Biomol Struct Dyn; 2021 Jan; 39(1):129-139. PubMed ID: 31900058
[TBL] [Abstract][Full Text] [Related]
23. The Structure of the Infectious Prion Protein and Its Propagation.
Requena JR; Wille H
Prog Mol Biol Transl Sci; 2017; 150():341-359. PubMed ID: 28838667
[TBL] [Abstract][Full Text] [Related]
24. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
Cobb NJ; Apetri AC; Surewicz WK
J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
[TBL] [Abstract][Full Text] [Related]
25. A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
Kakuda K; Yamaguchi KI; Kuwata K; Honda R
Biochem Biophys Res Commun; 2018 Nov; 506(1):81-86. PubMed ID: 30336980
[TBL] [Abstract][Full Text] [Related]
26. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
[TBL] [Abstract][Full Text] [Related]
27. Prion protein and its conformational conversion: a structural perspective.
Surewicz WK; Apostol MI
Top Curr Chem; 2011; 305():135-67. PubMed ID: 21630136
[TBL] [Abstract][Full Text] [Related]
28. β-cleavage of the human prion protein impacts Cu(II) coordination at its non-octarepeat region.
Sánchez-López C; Quintanar L
J Inorg Biochem; 2022 Mar; 228():111686. PubMed ID: 34929540
[TBL] [Abstract][Full Text] [Related]
29. Zinc significantly changes the aggregation pathway and the conformation of aggregates of human prion protein.
Pan K; Yi CW; Chen J; Liang Y
Biochim Biophys Acta; 2015 Aug; 1854(8):907-18. PubMed ID: 25922234
[TBL] [Abstract][Full Text] [Related]
30. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
[TBL] [Abstract][Full Text] [Related]
31. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
Soto C; Kascsak RJ; Saborío GP; Aucouturier P; Wisniewski T; Prelli F; Kascsak R; Mendez E; Harris DA; Ironside J; Tagliavini F; Carp RI; Frangione B
Lancet; 2000 Jan; 355(9199):192-7. PubMed ID: 10675119
[TBL] [Abstract][Full Text] [Related]
32. Transition of the prion protein from a structured cellular form (PrP
Baral PK; Yin J; Aguzzi A; James MNG
Protein Sci; 2019 Dec; 28(12):2055-2063. PubMed ID: 31583788
[TBL] [Abstract][Full Text] [Related]
33. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
34. Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions.
Thakur AK; Srivastava AK; Srinivas V; Chary KVR; Rao CM
J Biol Chem; 2011 Nov; 286(44):38533-38545. PubMed ID: 21900252
[TBL] [Abstract][Full Text] [Related]
35. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
36. The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein.
Giachin G; Nepravishta R; Mandaliti W; Melino S; Margon A; Scaini D; Mazzei P; Piccolo A; Legname G; Paci M; Leita L
PLoS One; 2017; 12(11):e0188308. PubMed ID: 29161325
[TBL] [Abstract][Full Text] [Related]
37. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange.
Lu X; Wintrode PL; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1510-5. PubMed ID: 17242357
[TBL] [Abstract][Full Text] [Related]
38. The cellular and pathologic prion protein.
Gill AC; Castle AR
Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138
[TBL] [Abstract][Full Text] [Related]
39. Structural transitions in full-length human prion protein detected by xenon as probe and spin labeling of the N-terminal domain.
Narayanan SP; Nair DG; Schaal D; Barbosa de Aguiar M; Wenzel S; Kremer W; Schwarzinger S; Kalbitzer HR
Sci Rep; 2016 Jun; 6():28419. PubMed ID: 27341298
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
Redecke L; Meyer-Klaucke W; Koker M; Clos J; Georgieva D; Genov N; Echner H; Kalbacher H; Perbandt M; Bredehorst R; Voelter W; Betzel C
J Biol Chem; 2005 Apr; 280(14):13987-92. PubMed ID: 15684434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
